OBERWEIS ASSET MANAGEMENT INC/ - PROGENICS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
OBERWEIS ASSET MANAGEMENT INC/ ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2018$137,000
+31.7%
17,100
+22.1%
0.03%
+25.9%
Q1 2018$104,00014,0000.03%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
ARDSLEY ADVISORY PARTNERS LP 1,255,000$5,823,0001.12%
Phocas Financial Corp. 1,146,292$5,319,0000.54%
Worth Venture Partners, LLC 138,357$641,0000.36%
RICE HALL JAMES & ASSOCIATES, LLC 2,293,179$10,640,0000.34%
Monashee Investment Management LLC 240,000$1,114,0000.26%
BKS ADVISORS, LLC 118,587$550,0000.22%
PINNACLE ASSOCIATES LTD 1,418,391$6,581,0000.15%
FARALLON CAPITAL MANAGEMENT LLC 4,200,820$19,492,0000.15%
Fosun International Ltd 472,580$2,174,0000.14%
CARILLON TOWER ADVISERS, INC. 3,948,024$18,318,0000.13%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders